Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2021
A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variantsNovalia Pishesha, Thibault J Harmand, Paul W Rothlauf, et al.
Cell Host & Microbe|August 1, 2020
Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
SSRN|July 28, 2020
Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cellMaritza Puray-Chavez, Kyle M LaPak, Travis P Schrank, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2020
Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusionRuochen Zang, James Brett Case, Eylan Yutuc, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
JIB-04 has broad-spectrum antiviral activity and inhibits SARS-CoV-2 replication and coronavirus pathogenesisJuhee Son, Shimeng Huang, Qiru Zeng, et al.
Mbio|January 18, 2022
JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus PathogenesisJuhee Son, Shimeng Huang, Qiru Zeng, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2021
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2Matthew McCallum, Anna De Marco, Florian Lempp, et al.
Cell|March 24, 2021
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2Matthew McCallum, Anna De Marco, Florian A Lempp, et al.
Pageof 4